Literature DB >> 20555085

Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

K Oberg1, P Hellman, D Kwekkeboom, S Jelic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555085     DOI： 10.1093/annonc/mdq191

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  30 in total

1.  The treatment of neuroendocrine tumors with long-acting somatostatin analogs: a single center experience with lanreotide autogel.

Authors:  A Bianchi; L De Marinis; A Fusco; F Lugli; L Tartaglione; D Milardi; M Mormando; A P Lassandro; R Paragliola; C A Rota; S Della Casa; S M Corsello; M G Brizi; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2011-11-07       Impact factor: 4.256

2.  Benefits of postoperative thoracic radiotherapy for small cell lung cancer subdivided by lymph node stage: a systematic review and meta-analysis.

Authors:  Shuling Zhang; Xin Sun; Li Sun; Zhicheng Xiong; Jietao Ma; Chengbo Han
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

3.  The role of surgery in high grade neuroendocrine tumours of the lung.

Authors:  Stefan Welter; Clemens Aigner; Christian Roesel
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.

Authors:  Yi Chen; Jinyu Li; Yi Hu; Yibao Zhang; Zhi Lin; Zhifei Zhao; Shunchang Jiao
Journal:  Strahlenther Onkol       Date:  2016-09-07       Impact factor: 3.621

5.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

6.  Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis.

Authors:  Amir Sabet; Alexander R Haug; Collin Eiden; Christoph J Auernhammer; Birgit Simon; Peter Bartenstein; Hans J Biersack; Samer Ezziddin
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-04-15

7.  Efficacy of substituted 9-aminoacridine derivatives in small cell lung cancer.

Authors:  Etchison Ryan; A Jacobson Blake; A Benoit; M Ferguson David; A Kratzke Robert
Journal:  Invest New Drugs       Date:  2012-07-22       Impact factor: 3.850

8.  The clinical significance of anti-mitotic spindle apparatus antibody (MSA) and anti-centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC).

Authors:  Liming Tan; Yuhong Zhang; Yongqing Jiang; Hua Li; Juanjuan Chen; Feng Ming; Waimei Wang; Jianlin Yu; Tingting Zeng; Yongjian Tian; Yang Wu
Journal:  Am J Clin Exp Immunol       Date:  2017-02-15

9.  It is feasible to operate on pathological Masaoka stage I and II thymoma patients with video-assisted thoracoscopy: analysis of factors for a successful resection.

Authors:  Alper Toker; Suat Erus; Sedat Ziyade; Berker Ozkan; Serhan Tanju
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

10.  Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute.

Authors:  Boram Han; Jong-Mu Sun; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.